Shanghai Medicilon (SHSE:688202) 3-Year Book Growth Rate : 13.40% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon 3-Year Book Growth Rate?

Shanghai Medicilon's Book Value per Share for the quarter that ended in Mar. 2025 was ¥15.78.

During the past 12 months, Shanghai Medicilon's average Book Value per Share Growth Rate was -13.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 13.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was 17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Shanghai Medicilon was 79.60% per year. The lowest was 13.40% per year. And the median was 41.90% per year.

Competitive Comparison of Shanghai Medicilon's 3-Year Book Growth Rate

For the Biotechnology subindustry, Shanghai Medicilon's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Medicilon's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

Shanghai Medicilon 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Shanghai Medicilon (SHSE:688202) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Shanghai Medicilon 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Medicilon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299

Website

http://www.medicilon.com.cn

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

Executives

Chen Jin Zhang	Director
Chen Guo Xing	Director
Lin Zhang Qing	Director
Peng Shuang Qing	Core technical personnel
Li Zhi Gang	Core technical personnel
Xu Yong Mei	Core technical personnel
Liu Bin Bin	senior management
Zhang Xiao Dong	senior management
Xue Chao	senior management
Ma Xing Quan	senior management
	Directors, senior managers, core technical personn
Cai Jin Na	Directors, senior managers

Shanghai Medicilon Headlines

No Headlines